Genomictree Inc. Capital Reinvestment Ratio
Genomictree Inc. capital reinvestment ratio. Genomictree Inc. (228760) has a Capital Reinvestment Ratio of 0.43x as of December 2022, meaning it reinvests 0% of its operating cash flow (₩4.29 Billion) in capital expenditures (₩1.82 Billion). Check total reinvestment intensity of Genomictree Inc. to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Genomictree Inc. (2022–2022)
Capital reinvestment ratio of Genomictree Inc. from 2022 to 2022. This chart tracks Genomictree Inc.'s Capital Reinvestment Ratio across 1 annual periods. Also explore 228760 net asset momentum to track the company's year-over-year net asset growth rate.
Genomictree Inc. Capital Reinvestment Ratio by Year (2022–2022)
Genomictree Inc. capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see Genomictree Inc. cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.43x | ₩4.29 Billion | ₩1.82 Billion | — |